| Name |
Period |
Previous Institution |
Degree |
Research Interest |
Current Position |
| Abraham Scaria |
1993 - 1994 |
St. Louis University |
Ph.D. |
Adenovirus Vectors |
Scientist @ Genzyme |
| M.L. Liu |
1993 - 1996 |
Chinese Academia of Sciences |
M.D. |
Retrovirus Vectors |
Research Associate in Seattle |
| Mary Hitt |
1994 - 1995 |
UC Berkeley |
Ph.D. |
Gene Expression in Adenovirus |
Assistant Professor @ University of Alberta |
| Marie-Jeanne T.F.D. Vrancken Peeters |
1994 - 1996 |
Leiden University |
M.D.
Ph.D. |
Hepatocyte Transplantation |
Surgeon @ Red Cross Hospital, Netherlands |
| Dave Schowalter |
1994 - 2000 |
Mayo Med. University |
M.D.
Ph.D. |
Adenoviral Immunology |
Deceased |
| Andre Lieber |
1995 - 1998 |
Inst. Med. Moscow & Humboldt Univ. |
M.D.
Ph.D. |
Hepatitis C |
Professor @ University of Washington |
| Jim Nelson |
1995 - 1999 |
Wayne State |
Ph.D. |
Adeno Vectors |
Clinical Trials Coordinator @ Univ. Washington |
| G.A. Patijn |
1996 - 1998 |
Leiden University |
M.D.
Ph.D. |
Hepatocyte Transplantation |
Consultant Gastrointestinal Surgeon @ Isala Clinics, Netherlands |
| Carol Miao |
1996 - 2000 |
University of Washington |
Ph.D. |
Hemophilia Gene Therapy |
Assistant Professor @ University of Washington |
| Hiroyuki Mizuguchi |
1997 - 1998 |
Osaka University |
Ph.D. |
Adenoviral Vectors |
Project Leader @ National Institute of Biomedical Innovation, Japan |
| Stephen Yant |
1997 - 2006 |
University of Michigan |
Ph.D. |
Integrating Gene Transfer Vectors |
Research Scientist @ Gilead |
| Kazuo Ohashi |
1998 - 2002 |
Nara Medical University |
M.D.
Ph.D. |
Liver Tissue Engineering; Cell-Based Gene Therapy, Hepatocyte Transplantation |
Assistant Professor @ Tokyo Women's Medical University |
| Frank Park |
1998 - 2002 |
Medical College of Wisonsin |
Ph.D. |
Lenti Vectors |
Assistant Professor @ Louisiana State University |
| Hiroyuki Nakai |
1998 - 2004 |
Kyoto Pref. University of Medicine |
M.D.
Ph.D. |
AAV Vectors |
Assistant Professor @ University of Pittsburgh |
| Peter Peng |
1999 - 2002 |
Stanford University |
M.S. |
Gene Therapy for Diabetes |
Fellow @ NIH |
| Brian Garrison |
1999 - 2002 |
UC Davis |
B.S. |
HCV Therapeutics |
Research Fellow @ Harvard University |
| Anton McCaffrey |
1999 - 2004 |
University of Colorado |
Ph.D. |
HCV Therapeutics |
Assistant Professor @ University of Iowa |
| Anja Ehrhardt |
1999 - 2004 |
University of Hannover |
Ph.D. |
Adenovirus Vectors |
Faculty @ Max von Pettenkofer Institute, Germany |
| Julie Park |
1999 - 2005 |
MIT |
B.S. |
Non-Viral Vectors |
Stanford University |
| Alfred Wang |
1999 - 2006 |
Stanford University |
M.S. |
|
|
| Chong W. Yung |
2000 - 2002 |
Harvard University |
M.S.
Ph.D. |
Regulatorable DNA Vectors |
Research Fellow in Surgery @ Harvard University |
| Konrad Streetz |
2000 - 2005 |
University of Hannover |
M.D.
Ph.D. |
Animal Models for Human Liver Cells |
The University Hospital, Aachen, Germany |
| Efren Riu Pastor |
2000-2007 |
Univ. of Barcelona |
Ph.D. |
Approaches for In Vivo Gene Therapy for Hemophilia |
Research Fellow @ Universitat Autònoma de Barcelona |
| Clare Thomas |
2001 - 2003 |
University of Leeds |
Ph.D. |
AAV Mechanism for Transduction |
Associate Editor for Nature Medicine |
| Jacob G. Mikkelsen |
2001 - 2003 |
Aarhus University |
Ph.D. |
Gene Transfer Vectors for Use in Human Gene Therapy |
Associate Professor @ Aarhus University |
| Nandita Nath |
2003 - 2004 |
University of Delhi |
Ph.D. |
Anti-Viral Therapies |
Scientist @ Milagen |
| Bassel Akache |
2005 - 2006 |
McGill University, Montreal, Quebec, Canada |
Ph.D. |
AAV Mechanism of Transduction |
Senior Research Scientist @ Methylgene Inc. |
| Xuan Shen |
2003-2007 |
University of South Caroina |
Ph.D. |
Viral Vectors, Gene Therapy and Liver Diseases |
Scientist, MedImmune |
| Michael Hebert |
2005-2007 |
University of Texas |
Ph.D. |
AAV and Hemophilia B |
Technical Specialist @ Foley & Lardner LLP |
| Dirk Grimm |
2001-2007 |
German Cancer Research Center (DKFZ), Heidelberg |
Ph.D. |
AAV and Hemophilia B |
Leader of CHS group 'Virus-Host Interactions'
University of Heidelberg |
| Dirk Haussecker |
2005-2009 |
Oxford University, United Kingdom |
Ph.D. |
HDV-mediated amplification of therapeutic RNAi |
TBD |